Cargando…
Hyperammonemic Encephalopathy due to Valproic Acid and Topiramate Interaction
Valproic acid-induced hyperammonemic encephalopathy is a rare yet serious adverse drug reaction. Medication interactions such a valproic acid and topiramate can precipitate an event. We present the case of a 52-year-old female that presented with acute mental status change and hypersomnolence due to...
Autores principales: | Twilla, Jennifer D., Pierce, Andrew S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4127233/ https://www.ncbi.nlm.nih.gov/pubmed/25136470 http://dx.doi.org/10.1155/2014/410403 |
Ejemplares similares
-
Hypoxic respiratory failure due to hyperammonemic encephalopathy induced by concurrent use of valproic acid and topiramate, a case report and review of the literature
por: Raru, Yonas, et al.
Publicado: (2018) -
Valproic Acid-induced Hyperammonemic Encephalopathy Promoted by Levetiracetam
por: Roh, Sook Young, et al.
Publicado: (2014) -
A Case of Valproic-Acid Induced Hyperammonemic Encephalopathy
por: Iqbal, Kinza, et al.
Publicado: (2021) -
Hyperammonemic Encephalopathy: valproic acid-induced adverse reaction
por: Gómez, E., et al.
Publicado: (2023) -
Valproate-induced hyperammonemic encephalopathy enhanced by topiramate and phenobarbitone: A case report and an update
por: Vivekanandan, S., et al.
Publicado: (2010)